PATENT CLAIM ANALYSIS

Application Number: 15773048
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "019300"]

Abstract:
The use of the C-terminal region of one or more phytocystatin(s) for the curative or prophylactic treatment of tumors and/or inhibition of metastases in mammals or other vertebrates. In one embodiment, the pharmaceutical composition of the invention comprises a pharmaceutically acceptable carrier and a polypeptide containing only the C-terminal region of one or more phytocystatin(s). In another embodiment, the composition of the invention comprises a gene construct for the in vivo expression of said polypeptide.

Claim (Index 5):
The composition according to  claim 3 , wherein said gene construct comprises an arrangement of two or more nucleotide sequences encoding said polypeptides fused in phase, repeated or in sequence of the same or different nucleotide sequences having equal or greater similarity to 70% with SEQ ID No: 5, or with identity equal to or greater identity to 70% with SEQ ID No: 5, for administration and expression of the polypeptide(s) directly into the mammalian/vertebrate organism.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.82979
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09610313', '11709868', '12774158', '14889656', '15549803']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704420141418392
- 35 USC 102 Novelty (BERT): 0.4947140863249418
- Combined Prediction Score: 0.7428692213601495
- Mean Citation Score: 210.04635
- Max Citation Score: 213.10278
- Similarity Product: 146.78012196282506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test